|
SGTB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.50449999966906E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.88730000306015E-08 |
| Normal-vs-Stage2 |
3.253900E-02 |
| Normal-vs-Stage3 |
3.031900E-02 |
| Normal-vs-Stage4 |
1.275980E-02 |
| Stage1-vs-Stage2 |
9.032000E-01 |
| Stage1-vs-Stage3 |
3.076300E-02 |
| Stage1-vs-Stage4 |
6.880300E-02 |
| Stage2-vs-Stage3 |
3.226800E-01 |
| Stage2-vs-Stage4 |
4.180400E-01 |
| Stage3-vs-Stage4 |
7.677800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63920000018081E-07 |
| Normal-vs-AfricanAmerican |
3.387600E-01 |
| Normal-vs-Asian |
8.175700E-02 |
| Caucasian-vs-AfricanAmerican |
1.084200E-01 |
| Caucasian-vs-Asian |
4.894000E-01 |
| AfricanAmerican-vs-Asian |
2.717600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.67949999999129E-06 |
| Normal-vs-Female |
1.395440E-04 |
| Male-vs-Female |
8.352600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.525980E-01 |
| Normal-vs-Age(41-60Yrs) |
4.93550000002507E-06 |
| Normal-vs-Age(61-80Yrs) |
5.88699999999331E-05 |
| Normal-vs-Age(81-100Yrs) |
1.202150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.086600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.863000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.528400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.260000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.191800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.837000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.961120E-04 |
| Normal-vs-Grade 2 |
2.30449999971682E-07 |
| Normal-vs-Grade 3 |
4.401500E-04 |
| Normal-vs-Grade 4 |
1.708400E-01 |
| Grade 1-vs-Grade 2 |
7.350600E-01 |
| Grade 1-vs-Grade 3 |
1.308450E-01 |
| Grade 1-vs-Grade 4 |
3.687800E-02 |
| Grade 2-vs-Grade 3 |
1.338220E-02 |
| Grade 2-vs-Grade 4 |
1.535940E-03 |
| Grade 3-vs-Grade 4 |
1.738810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.96109994909932E-09 |
| Normal-vs-ccB subtype |
1.801920E-03 |
| ccA subtype-vs-ccB subtype |
1.654210E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33199999999378E-05 |
| Normal-vs-N1 |
1.931220E-01 |
| N0-vs-N1 |
6.786800E-01 |
|
|
